Linde CFO Matthew J. White sells 86,833 shares
The reported activity includes option exercises, shares withheld for exercise-price and tax costs, and sales; listed holdings also include unexercised options and stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Linde plc Chief Financial Officer Matthew J. White exercised options for 228,175 ordinary shares on November 4, 2026, in four tranches at exercise prices of $118.71, $154, $173.13 and $176.63 per share. The transactions also included 141,342 shares delivered or withheld for payment of exercise price or tax liability and sales of 86,833 shares across four transactions at $524.25, $518.50, $520 and $525 per share. Other listed positions include 3,096 ordinary shares through a 401(k), 72,795 options at $118.71 expiring February 28, 2027, and 2,728 restricted stock units.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
16 txns
Insider
White Matthew J
Role
Chief Financial Officer
Sold
86,833 shs ($45.26M)
Approx. gross sale proceeds
$45.26M
Approx. exercise cost
$34.47M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) F9 | 64,665 | $0.00 | $0.00 |
| Exercise | Stock Options (right to buy) F3 | 72,795 | $0.00 | $0.00 |
| Exercise | Stock Options (right to buy) F15 | 43,695 | $0.00 | $0.00 |
| Exercise | Stock Options (right to buy) F3 | 47,020 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 72,795 | $118.71 | $8.64M |
| Exercise Price or Tax Liability | Ordinary Shares F1 | 42,700 | $517.17 | $22.08M |
| Exercise | Ordinary Shares | 64,665 | $154.00 | $9.96M |
| Exercise Price or Tax Liability | Ordinary Shares F1 | 40,289 | $517.65 | $20.86M |
| Sale | Ordinary Shares | 15,686 | $524.25 | $8.22M |
| Sale | Ordinary Shares | 30,095 | $518.50 | $15.60M |
| Sale | Ordinary Shares | 24,376 | $520.00 | $12.68M |
| Sale | Ordinary Shares | 16,676 | $525.00 | $8.75M |
| Exercise | Ordinary Shares | 43,695 | $173.13 | $7.56M |
| Exercise Price or Tax Liability | Ordinary Shares F1 | 28,009 | $523.10 | $14.65M |
| Exercise | Ordinary Shares | 47,020 | $176.63 | $8.31M |
| Exercise Price or Tax Liability | Ordinary Shares F1 | 30,344 | $520.98 | $15.81M |
| Holding | Stock Options (right to buy) F2 | -- | -- | -- |
| Holding | Stock Options (right to buy) F3 | -- | -- | -- |
| Holding | Restricted Stock Units F4, F5 | -- | -- | -- |
| Holding | Stock Options (right to buy) F6 | -- | -- | -- |
| Holding | Deferred Stock Units F7, F8 | -- | -- | -- |
| Holding | Stock Options (right to buy) F9 | -- | -- | -- |
| Holding | Stock Options (right to buy) F10 | -- | -- | -- |
| Holding | Stock Options (right to buy) F5 | -- | -- | -- |
| Holding | Stock Options (right to buy) F6 | -- | -- | -- |
| Holding | Restricted Stock Units F4, F11 | -- | -- | -- |
| Holding | Stock Options (right to buy) F12 | -- | -- | -- |
| Holding | Performance Share Units (RTSR) F4, F13 | -- | -- | -- |
| Holding | Restricted Stock Units F4, F14 | -- | -- | -- |
| Holding | Stock Options (right to buy) F3 | -- | -- | -- |
| Holding | Stock Options (right to buy) F15 | -- | -- | -- |
| Holding | Restricted Stock Units F4, F16 | -- | -- | -- |
| Holding | Stock Options (right to buy) F17 | -- | -- | -- |
| Holding | Restricted Stock Units F4, F18 | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 365,430 contracts (Direct);
Ordinary Shares — 166,189.608 shares (Direct);
Restricted Stock Units — 8,451 contracts (Direct);
Deferred Stock Units — 1,541.952 contracts (Direct);
Performance Share Units (RTSR) — 0 contracts (Direct);
Ordinary Shares — 3,096.221 shares (Indirect, 401(k))
Footnotes (18)
- F1. Ordinary shares withheld to cover exercise price and tax withholdings.
- F2. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
- F3. This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- F4. Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
- F5. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
- F6. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
- F7. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
- F8. Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
- F9. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- F10. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
- F11. Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
- F12. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
- F13. The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
- F14. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
- F15. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
- F16. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
- F17. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
- F18. Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
Key Figures
Options exercised: 228,175 shares
Option exercise tranche: 72,795 shares at $118.71 per share
Option exercise tranche: 64,665 shares at $154 per share
+5 more
8 metrics
Options exercised
228,175 shares
November 4, 2026
Option exercise tranche
72,795 shares at $118.71 per share
November 4, 2026
Option exercise tranche
64,665 shares at $154 per share
November 4, 2026
Option exercise tranche
43,695 shares at $173.13 per share
November 4, 2026
Option exercise tranche
47,020 shares at $176.63 per share
November 4, 2026
Shares delivered or withheld for payment of exercise price or tax liability
141,342 shares
November 4, 2026
Ordinary shares sold
86,833 shares
November 4, 2026
Ordinary shares held through a 401(k)
3,096 shares
Position listed on November 4, 2026
Key Terms
Stock Options (right to buy), Restricted Stock Units, Deferred Stock Units, Performance Share Units (RTSR), +1 more
5 terms
Stock Options (right to buy) financial
"Stock Options (right to buy)"
Restricted Stock Units financial
"Restricted Stock Units that will vest in full and payout"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Deferred Stock Units financial
"Deferred stock units acquired under the Linde Compensation Deferral Plan"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many LIN options did Matthew J. White exercise?
Matthew J. White exercised options for 228,175 ordinary shares on November 4, 2026, in four tranches at $118.71, $154, $173.13 and $176.63 per share. The same-day transactions included 141,342 shares delivered or withheld for payment of exercise price or tax liability.
AI-generated analysis. How Rhea-AI works. Not financial advice.
